title: [Reboxetine in the treatment of bulimia nervosa].
abstract: There is a substancial body of literature demonstrating the efficacy of selective serotonin reuptake inhibitors antidepressants (SSRI) in reducing binge eating and vomiting frequency in Bulimia Nervosa. Good therapeutic response to noradrenergic agents, like desipramine and reboxetine, though not frequently reported in literature, has already been demonstrated. This case report describes the treatment of Bulimia Nervosa with reboxetine (4 to 8 mg/day) and its favorable therapeutic results.
authors.affiliation: Instituto de Psiquiatria da Faculdade de Medicina da Universidade de São Paulo. São Paulo, SP, Brasil. simonemcastilho@hotmail.com
authors.forename: Simone Mancini
authors.initials: SM
authors.lastname: Castilho
authors.forename: Luiz Henrique Viegas
authors.initials: LH
authors.lastname: Costa
mesh_terms: D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use*; D002032:Bulimia / Q000188:drug therapy*; D005260:Female; D006801:Humans; D009025:Morpholines / Q000627:therapeutic use*; D000077593:Reboxetine
chemical_list: D000928:Antidepressive Agents; D009025:Morpholines; D000077593:Reboxetine
vernacular_title: Reboxetina no tratamento da bulimia nervosa.